Category

Events
Predicine will host a satellite symposium at the 2020 International Society of Liquid Biopsy (ISLB) Virtual Congress to discuss the clinical utility of circulating cell-free DNA and RNA liquid biopsy tests with a focus on MRD and early cancer detection. This symposium will bring together biomarker experts from Merck KGaA, Darmstadt, Germany, Washington University, and...
Predicine is excited to partner with Canadian Cancer Trials Group (CCTG) and contribute to a European Society for Medical Oncology (ESMO) featured presentation in pancreatic cancer. PredicineATLAS, a 600-gene cfDNA assay, is utilized in the CCTG PA.7 trial to assess the predictive value of blood TMB in metastatic pancreatic ductal adenocarcinoma patients treated with Durvalumab...
Date: June 22-24, 2020 Location: Virtual   Predicine will present three e-posters focusing on liquid biopsy methylation, urine biomarkers, and cfDNA+cfRNA molecular profiling, at the American Association for Cancer Research Virtual Meeting II, taking place June 22-24, 2020. For the first time, Predicine will present its proprietary methylation cell-free DNA (cfDNA) liquid biopsy technology for...
Date: May 29 – 31, 2020 Location: Virtual   In collaboration with Northwestern University and Peking University Cancer Hospital, we are presenting a poster at the American Society of Clinical Oncology Virtual Scientific Program. This study demonstrates that PredicineCARE blood-based ctDNA effectively detected the key mutations in HR+ metastatic breast cancer patients in US and...
Date: March 1-4, 2020 Location: Moscone South Convention Center, San Francisco, CA  Attend our presentation or schedule a meeting with us here. Presentation: Blood and Urine-based Liquid Biopsy Solutions for TMB and MRD in Clinical Trials In this talk, we’ll present the development and clinical applications of blood and urine-based liquid biopsy solutions using cfDNA...
Date: February 13 – 15, 2020 Location: Moscone West Building, San Francisco, CA  In collaboration with Mayo Clinic, Lee Moffitt Cancer Center, Monash University, and Kintor Pharmaceuticals, we are proud to announce our 3 abstracts in prostate cancer at the American Society of Clinical Oncology – Genitourinary Cancers Symposium.  Stop by our poster presentations or...
Date: January 13 – 16, 2020 Location: Hilton Miami Downtown, Miami, FL In collaboration with Merck KGaA, we are proud to present “Simultaneous multi-parametric profiling of cell-free RNA (cfRNA) and cell-free tumor DNA (ctDNA) in advanced-stage colorectal cancer” at the AACR Special Conference on Advances in Liquid Biopsies, on Tuesday, January 14th at 4:00pm, poster...
Date: December 10 – 14, 2019 Location: Henry B. Gonzalez Convention Center, San Antonio, TX Predicine is presenting new data from several studies at the San Antonio Breast Cancer Symposium 2019.  A list of the company’s presentations at SABCS is below.  Schedule a meeting with Predicine!   Featured abstracts at 2019 SABCS:   P2-11-09: Characterization...
Predicine is committed to supporting next-generation scientists in biomedical sciences. Through Predicine Translational Research Award at Harvard Medical School’s New England Science Symposium 2020 (NESS), we encourage students and fellows to innovate and explore careers in STEM. Every year students and fellows from around the U.S. and the world converge at the NESS to share their research...
September 27 – October 1, 2019 Barcelona, Spain Poster presentation: Peripheral cytotoxic T cell correlates with tumor mutational burden and is predictive for progression free survival in advanced breast cancer
1 2